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Abstract
Introduction: Noninvasive ventilation (NIV) is a standard procedure in selected patients with acute respiratory
failure. Previous studies have used noninvasive ventilation to ensure adequate gas exchange during fiberoptic
bronchoscopy in spontaneously breathing hypoxemic patients, thus avoiding endotracheal intubation. However, it
is unknown whether bronchoscopy can be performed safely in patients with acute hypoxemic respiratory failure
already in need of NIV prior to the decision for bronchoscopy.
Methods: We prospectively investigated 40 consecutive, critically ill, adult patients with acute hypoxemic
respiratory failure (14 women, 26 men, age 61 ± 15 years, partial pressure for oxygen/fraction of inspired oxygen
(PaO2/FiO2) < 300 under noninvasive ventilation, Simplified Acute Physiology scores (SAPS II) 47 ± 9.9 points). All
patients required noninvasive ventilation prior to the decision to perform bronchoscopy (median 10.5 h; range 2.2
to 114). Blood gases, heart rate, blood pressure and ventilation were monitored before, during and up to 120
minutes after bronchoscopy.
Results: Bronchoscopy could be completed in all patients without subsequent complications. Oxygen saturation
fell to < 90% in two patients (5%), and the lowest value during the procedure was 84%. The mean PaO2/FiO2 ratio
improved from 176 ± 54 at baseline to 240 ± 130 (P < 0.001) at the end of bronchoscopy and 210 ± 79 after 120
minutes. The transient mean partial pressure of carbon dioxide in the arterial blood (PaCO2) increase was 9.4 ± 8.1
mm Hg. Four patients (10%) required endotracheal intubation during the first eight hours after the procedure.
Bronchoalveolar lavage yielded diagnostic information in 26 of 38 (68%) patients.
Conclusions: In critically ill patients with acute hypoxemic respiratory failure requiring noninvasive ventilation,
bronchoscopy can be performed with an acceptable risk. Since these patients per se have a high likelihood of
subsequent endotracheal intubation due to failure of NIV, bronchoscopy should only be performed by experienced
clinicians.
Introduction
Noninvasive ventilation (NIV) constitutes a cornerstone
in the treatment of acute respiratory failure of various
etiologies [1-3]. Some patients treated for acute respira-
tory failure in the intensive care unit will require diagnos-
tic or therapeutic bronchoscopy. While bronchoscopy is
generally considered a safe intervention [4], it is well
known that bronchoscopy and especially bronchoalveolar
lavage (BAL) may induce significant hypoxemia [5].
Therefore, severe hypoxemia represents a contraindica-
tion for bronchoscopy unless it can be reversed by thera-
peutic interventions. Especially in hypoxemic patients the
known benefits of the procedure have to be weighed
against possible risks [6].
Small case series and few randomized controlled stu-
dies have suggested that NIV can prevent respiratory
deterioration in spontaneously breathing hypoxemic
patients undergoing bronchoscopy [7-13]. In these
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initiated to facilitate bronchoscopy and the study popu-
lation did not require NIV for hypoxemia at that point
in time. However, it is unknown whether bronchoscopy
can be performed with acceptable risk in patients with
acute hypoxemic respiratory failure already in need of
NIV prior to the decision for bronchoscopy. These
patients represent a population with substantially more
r e s p i r a t o r yc o m p r o m i s et h a nt h o s ef r o mt h ep r e v i o u s
studies mentioned above [7-13].
We, therefore, conducted a prospective study to assess
the feasibility of fiberoptic bronchoscopy in critically ill
patients already requiring NIV due to acute hypoxemic
respiratory failure prior to the bronchoscopy procedure.
Material and methods
Study design
The study was an observational, prospective cohort
study. It was approved by the ethics committee of the
chamber of physicians in Hamburg, Germany and was
performed in accordance with the ethical standards
laid down in the Declaration of Helsinki. Patients
admitted between November 2007 and January 2010
to the Department of Intensive Care Medicine, Uni-
versity Medical Center Hamburg-Eppendorf were eli-
gible for enrolment into the study. All participants or
their legal representatives gave written informed
consent.
Study subjects
The patient population included consecutive medical,
neurological and surgical intensive care unit (ICU)
patients. Inclusion criteria were: 1) acute hypoxemic
respiratory insufficiency with consecutive hypoxemia,
defined as PaO2/FiO2 < 300 under noninvasive ventila-
tion, 2) requiring NIV prior to bronchoscopy, 3) requir-
ing fiberoptic bronchoscopy for diagnostic or
therapeutic reasons, 4) age ≥18 years, and 5) informed
consent. Patients in whom NIV was instituted purely to
facilitate bronchoscopy were excluded. The decision
both to initiate NIV and to perform a bronchoscopy was
made by the attending intensivist on clinical grounds
and in accordance with published guidelines [14]. Sim-
plified acute physiology scores (SAPS II) were calculated
using standard criteria [15]. Immunosuppression was
defined as absolute neutrophil count < 1,000/mL, immu-
nosuppressive medication, organ transplantation, high
dose chemotherapy during the past 60 days, or acquired
immunodeficiency syndrome. Standard microbiological
diagnostic measures prior to bronchoscopy included
blood cultures and urinary antigen assay for Legionella.
While sputum cultures were rarely used, additional sero-
logical studies were ordered in immunosuppressed
patients as indicated.
Noninvasive ventilation
According to inclusion criteria, all patients were on NIV
prior to and throughout the bronchoscopy procedure.
ICU ventilators were used with the NIV option activated
(Evita 4, Dräger, Germany). The ventilator mode was set
to pressure support (CPAP/ASB) or pressure controlled
mode (BIPAP). Inspiratory pressure was set in the range
from 10 to 25 cm H2O and positive end-expiratory pres-
sure (PEEP) from 5 to 10 cm H2O to achieve optimal
ventilation and oxygenation. Ventilator settings were
adjusted by the attending intensivists. Simple full-face
masks (B+P, Neunkirchen-Seelscheid, Germany) were
used as interfaces secured to the patient’s face with elas-
tic straps. The time from initiation of NIV to the
bronchoscopy procedure was recorded. Following
bronchoscopy all patients remained on noninvasive ven-
tilatory support for at least two hours.
Bronchoscopy procedure
Before, during and after the bronchoscopy, the electro-
cardiogram, invasive blood pressure, pulse oximeter
(Infinity Omega, Dräger, Germany) and ventilatory para-
meters (FiO2, ventilator mode, in- and expiratory pres-
sures, tidal volume, and respiratory rate) were
continuously monitored. Arterial samples were drawn
for blood gas analysis from the arterial line at baseline,
at the end of the procedure with the bronchoscope still
placed in the trachea, and 15, 30, 45, 60, and 120 min-
utes after removal of the bronchoscope. Ventilator set-
tings were adjusted to optimize ventilatory support. The
fraction of inspired oxygen (FiO2) was increased to 1.0
after the baseline blood gas analysis was obtained and
kept constant throughout the procedure. After comple-
tion of bronchoscopy, FiO2 was reduced to the level at
which it was set prior to the procedure and adjusted to
maintain an arterial saturation of oxygen (SaO2)>9 0 % .
Figure 1 shows the schedule of the study procedures. A
swivel connector (T-adapter) was inserted between the
ventilator tubing and the mask to allow the insertion of
the endoscope (BF-P60, Olympus, Japan), see Figure 2.
Sedation was achieved following clinical protocols using
a combination of a single dose of 1 to 2 mg midazolam
i.v. and repetitive bolus applications of 10 to 20 mg pro-
pofol i.v. every two to three minutes. Following applica-
tion of lidocaine gel the bronchoscope was introduced
nasally or orally. Topical anesthesia (5 ml lidocaine
0.8%) was applied as a spray via the bronchoscope chan-
nel to the laryngeal, tracheal and bronchial mucosa.
All bronchoscopies were performed by experienced
physicians (HJB, SAB, MS, HK, SK). The decision to
p e r f o r maB A Lw a sn o tp a r to ft h es t u d ya n dw a s ,
therefore, left to the discretion of the attending intensi-
vist. The bronchoscope was wedged in the appropriate
subsegmental ostium and NaCl 0.9% solution was
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amount of BAL fluid used was determined by the num-
ber of diagnostic tests ordered. BAL fluid was subjected
to microscopic analysis and culturing as previously
described [16,17]. The duration of bronchoscopy was
defined as the time from insertion until removal of the
bronchoscope from the tracheobronchial tree.
Outcome
Outcomes evaluated were intubation rate within eight
hours of completion of bronchoscopy, intubation rate at
any time, length of ICU stay, and mortality. Intubation
was considered a complication possibly related to
bronchoscopy, if it occurred within eight hours of the
procedure. This time span was adopted from previous
studies [11,18]. The decision to intubate was left to the
discretion of the attending intensivists in accordance
with published guidelines [14]. In addition, patients
were monitored for other adverse events (for example,
hemorrhage, pneumothorax, hypotension, arrhythmia)
that occurred during the procedure and in the 24 hours
following the bronchoscopy, which could possibly be
related to the procedure.
Statistical analysis
Results are expressed as the mean ± standard deviation
(SD) for continuous variables if normally distributed and
as median with 95% confidence intervals if not. For
repeated measures one-way ANOVA was used to detect
significant differences between cardiorespiratory para-
meters at baseline, at the end of the bronchoscopy, and
after 15, 30, 45, 60, and 120 minutes; P-values of 0.05 or
less were considered significant.
Results
Patient characteristics
The study group consisted of 40 subjects. Patient char-
acteristics are shown in Table 1. Median PaO2/FiO2
prior to initiation of NIV was 117 ± 72, mean PaCO2
was 40 ± 13 mm Hg. The median duration of continu-
ous NIV prior to bronchoscopy was 10.5 h (range 2.2 to
Figure 1 Design of the study. NIV, noninvasive ventilation; FiO2, fraction of inspired oxygen.
Figure 2 Bronchoscope inserted through swivel connector in
the face mask.
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to 1.0 in all patients during the bronchoscopy proce-
dure. Within 30 minutes after the bronchoscopy mean
FiO2 level returned to the baseline level.
Sedation was given to all patients: 27 received both
midazolam (2.0 ± 0.8 mg) and propofol (69 ± 41 mg),
while 13 patients (33%) received propofol alone (61 ± 33
mg).
Tolerance of the procedure
The average duration of bronchoscopy was 7.8 ± 5.5
minutes (range 3.5 to 37.0 minutes). In all cases
bronchoscopy was completed without subsequent com-
plications. Two patients developed transient SaO2 values
below 90% during the procedure, the minimum SaO2
was 84%. Table 2 shows the course of cardiorespiratory
parameters before, during and after the bronchoscopy.
Significant changes from baseline were observed for
PaO2/FiO2,P a C O 2 and pH at the end of bronchoscopy,
and 15 and 30 minutes after completion of the proce-
dure, see Figure 3A. The average increase in PaCO2
from baseline to end of bronchoscopy was 9.4 ± 8.1 mm
Hg, see Figure 3B.
Baseline vs. post-bronchoscopy PaO2/FiO2 did not dif-
fer between patients who underwent bronchoscopy due
to suspected lower airways infection (189 ± 53 vs. 261 ±
160) vs. patients with suspected retention of secretions
(159 ± 52 vs. 213 ± 92).
The amount of sedation delivered was not related to
the increase in PaCO2. Mean heart rate and arterial
pressure did not change significantly during the proce-
dure. No patient needed initiation or dose adjustments
of vasopressors during the procedure. No other adverse
events, such as hemorrhage, arrhythmia, or pneu-
mothorax, were detected.
All but two patients remained on NIV until the end of
the 120-minute period following bronchoscopy. The two
patients stopped NIV after 60 minutes and breathed
oxygen with flow rates of 5 and 10 L/minute. Both these
patients had suspected lower airways infection as the
indication to perform bronchoscopy.
Results of fiberoptic bronchoscopy
Table 3 shows the clinical and microbiological results of
the bronchoscopy procedures.
Outcome
Four patients (10%) had to be intubated in the pre-specified
interval of eight hours following bronchoscopy. Underlying
diagnoses were suspected pneumonia in AIDS, suspected
pneumonia in leukemia, and suspected retention of secre-
tions in two patients following thoracic surgery. These
events were considered to be related to the bronchoscopy.
None of them were hypercapnic at baseline, but their
PaO2/FiO2 ratio under NIV was significantly lower than
the rest of the study population (136 vs. 180, P < 0.05).
Two of the four patients died, one patient on the subse-
quent day due to cardiogenic shock, the other 25 days later.
In addition, in the first 48 hours another patient died with-
out being intubated due to progressive liver failure.
In total, intubation was necessary in 22 (55%) patients.
The median interval from bronchoscopy to intubation
w a s2 7 . 4h( r a n g e2 . 3t o2 6 0h ,9 5 %C I2 3 . 3t o7 3 . 8h ) .
Forty-eight hours after the bronchoscopy a total of 18
patients (45%) were intubated. Overall ICU mortality
was 37.5% (15/40), hospital mortality 43% (17/40).
Discussion
Our results demonstrate a low complication rate for
fiberoptic bronchoscopy in critically ill patients with
acute hypoxemic respiratory failure requiring noninva-
sive ventilation already prior to bronchoscopy. Only
four patients needed endotracheal intubation during the
first eight hours following bronchoscopy (10%), a result
which falls within acceptable range.
Table 1 Patient characteristics, values given as mean ±
SD or no (%)
No. of patients 40
Sex ratio (m/f) 26/14
Age, years 61 ± 15
SAPS II score 47 ± 9.9
Thrombopenia < 50,000/mm
3 6 (15)
Immunosuppression 21 (53)
Use of vasopressors 12 (30)
Antibiotic therapy 37 (93)
Antimycotic therapy 12 (30)
Antiviral therapy 5 (13)
Underlying diagnosis
Acquired immunodeficiency syndrome 6 (15)
Hematopoietic stem cell transplantation 6 (15)
COPD 6 (15)
Thoracic surgery 4 (10)
Solid cancer 4 (10)
Hematologic malignancy 3 (8)
Pulmonary embolism 2 (5)
Pulmonary fibrosis 2 (5)
Other 7 (18)
Indication for bronchoscopy
Suspected lower airways infection 23 (58)
Suspected retention of secretions 16 (40)
Suspected stump insufficiency 1 (3)
Ventilator mode at baseline
Pressure support (CPAP/ASB) 30 (75)
Pressure control (BIPAP) 10 (25)
BIPAP, biphasic positive airway pressure; COPD, chronic obstructive pulmonary
disease; CPAP/ASB, continuous positive airway pressure with assisted
spontaneous breathing; SAPS II, Simplified acute physiology score II
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pre-existing studies [7-13,18,19] on bronchoscopy under
noninvasive ventilatory support is that NIV had already
been established in our patients irrespective of a
planned bronchoscopy. In the above mentioned previous
studies NIV was initiated primarily to facilitate broncho-
scopy. These differences of timing and reason for NIV
characterize our study population as more critically ill
in terms of hypoxemia than those of previous studies.
This needs to be taken into consideration when inter-
preting the average PaO2/FiO2 ratio of 176 ± 54 in our
study, since it was determined under conditions of NIV
as opposed to the average PaO2/FiO2 ratios reported in
the above mentioned studies, which were recorded in
Table 2 Cardiorespiratory parameters, values given as mean ± SD
Baseline End of bronchoscopy 15 minutes 30 minutes 45 minutes 60 minutes 120 minutes
Heart rate
(beats/
minute)
99 ± 18 97 ± 17 97 ± 17 97 ± 17 95 ± 18 94 ± 18 92 ± 17
MAP
(mm Hg)
88 ± 18 81 ± 17 83 ± 17 86 ± 17 84 ± 18 84 ± 14 83 ± 14
Respiratory rate
(breaths/min)
2 7±7 2 7±8 3 0±1 0 2 9±9 2 8±7 2 8±8 2 7±8
PaO2/
FiO2
176 ± 54 240 ± 130
a 242 ± 99
a 215 ± 76
c 207 ± 70 199 ± 68 210 ± 79
PaCO2
(mm Hg)
43 ± 14 53 ± 16
a 50 ± 15
a 47 ± 14
c 45 ± 13 44 ± 12 42 ± 13
pH 7.37 ± 0.09 7.30 ± 0.08
a 7.31 ± 0.07
a 7.34 ± 0.08
b 7.35 ± 0.09 7.36 ± 0.09 7.37 ± 0.08
a: P < 0.001 compared to baseline
b: P < 0.01 compared to baseline
c:P < 0.05 compared to baseline
MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; PaCO2, partial pressure of carbon dioxide in the arterial blood; PaO2, partial pressure of oxygen in
the arterial blood
Figure 3 Changes of PaO2/FiO2 (A) and PaCO2 (B), values given
as mean ± SD.# :P < 0.001 compared to baseline; *: P < 0.05
compared to baseline.
Table 3 Results of fiberoptic bronchoscopy (n = 40)
No. of patients undergoing BAL 38 (95)
Instilled volume during BAL (ml) 110 (108 to 112)
Recovered BAL fluid (ml) 38 (31 to 44)
Microbiolocial results
Candida species (colonisation) 18 (45)
obligate or potentially pathogenic organisms 25 (66)
Corynebacterium 3 (8)
Staphylococcus aureus 3 (8)
Escherichia coli 2 (5)
Citrobacter species 1 (3)
Enterobacter species 1 (3)
Methicillin resistant Staph. aureus 1 (3)
Neisseria species 1 (3)
Proteus species 1 (3)
Pseudomonas species 1 (3)
Serratia marcescens 1 (3)
Pneumocystis jirovecii 4 (11)
Cytomegalovirus 3 (8)
Herpes simplex virus 3 (8)
Bronchialcarcinoma 1 (3)
Treatment changes 13 (34)
Values given as number (%) or median (95% CI). Percent values of
bronchoalveolar lavage (BAL) results refer to the group of 38 patients
undergoing BAL
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of 117 ± 72 under spontaneous breathing prior to NIV
initiation in our population represents one of the lowest
value when compared to the existing literature.
The difference in disease severity is also reflected in a
higher average SAPS II score (47 ± 9.9) of our popula-
tion in comparison to that of previous studies. To our
knowledge, the present study is the largest of its kind.
Previous reports describe small numbers of patients
under NIV requiring bronchoscopy [7,10,18,20]. How-
ever, our study, enrolling 40 patients, represents the
most extensive and comprehensive report on critically ill
patients requiring NIV due to acute respiratory failure
and subsequent bronchoscopy.
It is difficult to determine whether the intubation of
four patients (10%) within the pre-specified period of
eight hours following bronchoscopy was due to the nat-
ural clinical course of the underlying disease or related
to the intervention itself. In several reports studying
NIV-failure rates in patients with acute hypoxemic
respiratory failure it was consistently shown that 1) this
patient group has per se an intubation rate exceeding
50% and 2) once intubation is necessary this occurs
within the first 24 to 48 hours in the majority of
patients [21-24].
In comparison, our patients who had been on NIV for a
median duration of 10.5 hours prior to bronchoscopy
required an intubation in 45% of cases within the first 48
hours following bronchoscopy. Therefore, we believe that
the reported intubation rate of 10% in the first eight hours
after bronchoscopy falls within an acceptable range.
Surprisingly we did not find significant changes in the
gas exchange before and after bronchoscopy between
the two groups of patients with suspected lower airways
infection versus suspected retained secretions. This
observation might be explained by the small clinical dif-
ferences of these two groups: While almost all patients
(38/40) underwent BAL, only very few patients showed
relevant amounts of secretions in contrast to prior
expectations before the procedure. The increase in
PaO2/FiO2 ratio immediately after bronchoscopy cannot
be explained by removal of secretions but may be attri-
butable to other mechanisms.
Previously reported studies on bronchoscopy under
NIV involved different methods of sedation. While
Antonelli et al. exclusively used topical anaesthesia
[7-9], others reported on sedation in subgroups of “agi-
tated” patients [12]. Hilbert et al. described difficulties
in performing bronchoscopy in severely hypoxemic
patients without sedation and used analgosedation in all
patients [18]. In our study, all patients received mild
sedation using a combination of propofol and midazo-
lam or propofol alone. We observed a mean increase of
PaCO2 of 9.4 ± 8.1 mmHg that is in accordance with
the results of studies on sedation during bronchoscopy
in less critically ill and spontaneously breathing patients.
Our study has some limitations. First, we do not know
whether performing bronchoscopy without sedation
would have resulted in smaller increases of PaCO2 and
possibly fewer intubations. As procedural sedation is the
routine standard of care in our institution and no
reports exist of bronchoscopy under NIV in similar
patients, we considered it inappropriate to perform a
controlled study.
Second, it should be emphasized that experienced
clinicians performed all bronchoscopies. Therefore, our
results may not be generalizable to other settings and, if
less experienced physicians perform the procedures, a
more cautious strategy may be appropriate. Third, as all
results are influenced by the studied population, our
conclusions are only applicable to patient populations
with similar characteristics.
Conclusions
We found that bronchoscopy can be performed with
acceptable risk in patients with severe acute hypoxemic
respiratory failure already on noninvasive ventilatory
support. Since these patients per se have a high risk of
endotracheal intubation secondary to NIV failure,
bronchoscopy should only be performed by clinicians
experienced with bronchoscopy and endotracheal intu-
bation in an environment with a high level of
monitoring.
Key messages
￿ Noninvasive ventilation (NIV) facilitates broncho-
scopy in patients with acute hypoxemic respiratory
failure.
￿ Our study shows that even patients already requir-
ing NIV due to acute hypoxemic respiratory failure
may undergo bronchoscopy with acceptable risk.
￿ As these patients a priori have a high risk of NIV
failure, only experienced staff should perform
bronchoscopy in this patient population.
￿ In our study, BAL results revealed obligate or
potentially pathogenic organisms in 25/38 patients
(66%) and lead to treatment changes in 13/38 (34%)
of patients.
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